Utilization Patterns of Obesity Drugs

Project Title Utilization Patterns of Obesity Drugs
Date Posted
Tuesday, March 19, 2019
Project ID
cder_mpl1r_wp129
Status
Complete
Deliverables
Sentinel Modular Program Report: Utilization Patterns of Obesity Drugs, Report 1
Sentinel Modular Program Report: Utilization Patterns of Obesity Drugs, Report 2
Related Links
Use of SGLT-2 Inhibitors and Obesity Drugs
2019 ICPE Poster: Utilization of Prescription Anti-Obesity Drugs in the U.S. Food and Drug Administration's (FDA) Sentinel System, 2008-2017
Description

This request examines utilization patterns of nine obesity drugs in the Sentinel Distributed Database (SDD) between January 1, 2008 and December 31, 2017. This request was distributed to 17 Data Partners on December 21, 2018.
Medical Product
benzphetamine
bupropion/naltrexone
diethylpropion
liraglutide
lorcaserin HCl
orlistat
phendimetrazine
phentermine HCl
phentermine/topiramate
Population / Cohort
Individuals 18 years of age and older
Time Period
January 1, 2008 - December 31, 2017
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER